Statins and Cognition in Parkinson's Disease.

about

Simvastatin as a Potential Disease-Modifying Therapy for Patients with Parkinson's Disease: Rationale for Clinical Trial, and Current Progress.

P2860

Q45201060-6C68AC7C-BA1B-40F4-8C42-FCFCECF96858

P2860

Statins and Cognition in Parkinson's Disease.

Item

http://www.wikidata.org/entity/Q46305058

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Statins and Cognition in Parkinson's Disease.

@en

Statins and Cognition in Parkinson's Disease.

@nl

type

Item

label

Statins and Cognition in Parkinson's Disease.

@en

Statins and Cognition in Parkinson's Disease.

@nl

prefLabel

Statins and Cognition in Parkinson's Disease.

@en

Statins and Cognition in Parkinson's Disease.

@nl

P1476

Statins and Cognition in Parkinson's Disease

@en

P2093

Alice Chen-Plotkin

http://www.w3.org/2001/XMLSchema#string

Daniel Weintraub

http://www.w3.org/2001/XMLSchema#string

Jacqueline Rick

http://www.w3.org/2001/XMLSchema#string

James F Morley

http://www.w3.org/2001/XMLSchema#string

John E Duda

http://www.w3.org/2001/XMLSchema#string

John Q Trojanowski

http://www.w3.org/2001/XMLSchema#string

Nabila Dahodwala

http://www.w3.org/2001/XMLSchema#string

Sharon X Xie

http://www.w3.org/2001/XMLSchema#string

P2860

Statins for the prevention of dementia

Pleiotropic effects of statins

Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease

Lower plasma apolipoprotein A1 levels are found in Parkinson's disease and associate with apolipoprotein A1 genotype

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

Parkinsonism: onset, progression and mortality

General cardiovascular risk profile for use in primary care: the Framingham Heart Study

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment

Plasma apolipoprotein A1 as a biomarker for Parkinson disease

P304

661-667

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3233/JPD-171113

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Lana M Chahine

Benjamin L Deck

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28922167

http://www.w3.org/2001/XMLSchema#string

P932

5675567

http://www.w3.org/2001/XMLSchema#string

Statins and Cognition in Parkinson's Disease.

about

P2860

P2860

Statins and Cognition in Parkinson's Disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932